FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.22-SNAPSHOT  |  FHIR Version n/a  User: [n/a]

1179527004: Product containing precisely lidocaine hydrochloride 40 milligram/1 gram and metronidazole 10 milligram/1 gram and sucralfate 70 milligram/1 gram conventional release cutaneous cream (clinical drug)


Status: current, Sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Oct 2021. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module
4651609012 Lidocaine hydrochloride 40 mg/g and metronidazole 10 mg/g and sucralfate 70 mg/g cutaneous cream en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
4651610019 Product containing precisely lidocaine hydrochloride 40 milligram/1 gram and metronidazole 10 milligram/1 gram and sucralfate 70 milligram/1 gram conventional release cutaneous cream (clinical drug) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core


0 descendants.

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Lidocaine hydrochloride 40 mg/g and metronidazole 10 mg/g and sucralfate 70 mg/g cutaneous cream Is a Lidocaine- and metronidazole- and sucralfate-containing product in cutaneous dose form true Inferred relationship Some
Lidocaine hydrochloride 40 mg/g and metronidazole 10 mg/g and sucralfate 70 mg/g cutaneous cream Has manufactured dose form Cutaneous cream true Inferred relationship Some
Lidocaine hydrochloride 40 mg/g and metronidazole 10 mg/g and sucralfate 70 mg/g cutaneous cream Plays role Antibacterial therapeutic role (role) false Inferred relationship Some
Lidocaine hydrochloride 40 mg/g and metronidazole 10 mg/g and sucralfate 70 mg/g cutaneous cream The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). Metronidazole (substance) true Inferred relationship Some 1
Lidocaine hydrochloride 40 mg/g and metronidazole 10 mg/g and sucralfate 70 mg/g cutaneous cream This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. Metronidazole (substance) true Inferred relationship Some 1
Lidocaine hydrochloride 40 mg/g and metronidazole 10 mg/g and sucralfate 70 mg/g cutaneous cream This attribute specifies the numerator unit for the concentration strength of a product. mg true Inferred relationship Some 1
Lidocaine hydrochloride 40 mg/g and metronidazole 10 mg/g and sucralfate 70 mg/g cutaneous cream This attribute specifies the denominator unit for the concentration strength of a product. g true Inferred relationship Some 1
Lidocaine hydrochloride 40 mg/g and metronidazole 10 mg/g and sucralfate 70 mg/g cutaneous cream The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). Sucralfate (substance) true Inferred relationship Some 2
Lidocaine hydrochloride 40 mg/g and metronidazole 10 mg/g and sucralfate 70 mg/g cutaneous cream This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. Sucralfate (substance) true Inferred relationship Some 2
Lidocaine hydrochloride 40 mg/g and metronidazole 10 mg/g and sucralfate 70 mg/g cutaneous cream This attribute specifies the numerator unit for the concentration strength of a product. mg true Inferred relationship Some 2
Lidocaine hydrochloride 40 mg/g and metronidazole 10 mg/g and sucralfate 70 mg/g cutaneous cream This attribute specifies the denominator unit for the concentration strength of a product. g true Inferred relationship Some 2
Lidocaine hydrochloride 40 mg/g and metronidazole 10 mg/g and sucralfate 70 mg/g cutaneous cream The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). Lidocaine hydrochloride true Inferred relationship Some 3
Lidocaine hydrochloride 40 mg/g and metronidazole 10 mg/g and sucralfate 70 mg/g cutaneous cream This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. Lidocaine hydrochloride true Inferred relationship Some 3
Lidocaine hydrochloride 40 mg/g and metronidazole 10 mg/g and sucralfate 70 mg/g cutaneous cream This attribute specifies the numerator unit for the concentration strength of a product. mg true Inferred relationship Some 3
Lidocaine hydrochloride 40 mg/g and metronidazole 10 mg/g and sucralfate 70 mg/g cutaneous cream This attribute specifies the denominator unit for the concentration strength of a product. g true Inferred relationship Some 3

Inbound Relationships Type Active Source Characteristic Refinability Group

This concept is not in any reference sets

Back to Start